Investor Presentaiton

Proprietary Products: Building $500 million business by FY22 business through lower-risk innovation model Reverse Translation-based Product Development Engine Promius Pharma: A unique, unmet-need driven Specialty Dermatology and Neurology company Commercialization Model focused on solving patient challenges [focusing directly on both physician and patient] Investor Presentation - 2016 Dr. Reddy's Laboratories Ltd. 27

View entire presentation